|
GB9604926D0
(en)
*
|
1996-03-08 |
1996-05-08 |
Sandoz Ltd |
Organic compounds
|
|
EP2402320A1
(en)
|
2006-03-31 |
2012-01-04 |
Novartis AG |
Anorectic agents
|
|
ES2333539T3
(es)
|
2006-04-21 |
2010-02-23 |
Cellzome Limited |
Derivados de terfenilo para el tratamiento de la enfermedad de alzheimer.
|
|
WO2008008059A1
(en)
|
2006-07-12 |
2008-01-17 |
Locus Pharmaceuticals, Inc. |
Anti-cancer agents ans uses thereof
|
|
WO2011082400A2
(en)
|
2010-01-04 |
2011-07-07 |
President And Fellows Of Harvard College |
Modulators of immunoinhibitory receptor pd-1, and methods of use thereof
|
|
JP6238459B2
(ja)
|
2011-08-01 |
2017-11-29 |
ジェネンテック， インコーポレイテッド |
Ｐｄ−１軸結合アンタゴニストとｍｅｋ阻害剤を使用する癌の治療方法
|
|
EP2780338B1
(en)
|
2011-11-14 |
2016-11-09 |
Ignyta, Inc. |
Uracil derivatives as axl and c-met kinase inhibitors
|
|
EP2788000B1
(en)
|
2011-12-06 |
2018-05-30 |
Merck Sharp & Dohme Corp. |
Pyrrolopyrimidines as janus kinase inhibitors
|
|
JP6417419B2
(ja)
|
2013-09-04 |
2018-11-07 |
ブリストル−マイヤーズ スクイブ カンパニーＢｒｉｓｔｏｌ−Ｍｙｅｒｓ Ｓｑｕｉｂｂ Ｃｏｍｐａｎｙ |
免疫調節剤として有用な化合物
|
|
SI3041828T1
(sl)
|
2013-09-06 |
2018-10-30 |
Aurigene Discovery Technologies Limited |
1,3,4-oksadiazolni in 1,3,4-tiadiazolni derivati kot imunomodulatorji
|
|
HRP20181052T1
(hr)
|
2013-09-06 |
2018-09-07 |
Aurigene Discovery Technologies Limited |
Derivati 1,2,4-oksadiazola kao imunomodulatori
|
|
US9850225B2
(en)
|
2014-04-14 |
2017-12-26 |
Bristol-Myers Squibb Company |
Compounds useful as immunomodulators
|
|
JP6767096B2
(ja)
|
2014-12-11 |
2020-10-14 |
リティックス バイオファーマ エイエス |
免疫チェックポイント阻害剤の組み合わせ
|
|
JP2018507884A
(ja)
*
|
2015-03-10 |
2018-03-22 |
オーリジーン ディスカバリー テクノロジーズ リミテッドＡｕｒｉｇｅｎｅ Ｄｉｓｃｏｖｅｒｙ Ｔｅｃｈｎｏｌｏｇｉｅｓ Ｌｉｍｉｔｅｄ |
免疫調節剤としての３−置換１，３，４−オキサジアゾールおよびチアジアゾール化合物
|
|
NL1041468B1
(en)
|
2015-09-08 |
2017-03-22 |
Bosch Gmbh Robert |
Metal ring component of a drive belt for a continuously variable transmisson.
|
|
US10745382B2
(en)
|
2015-10-15 |
2020-08-18 |
Bristol-Myers Squibb Company |
Compounds useful as immunomodulators
|
|
EP3365340B1
(en)
|
2015-10-19 |
2022-08-10 |
Incyte Corporation |
Heterocyclic compounds as immunomodulators
|
|
US20170145025A1
(en)
|
2015-11-19 |
2017-05-25 |
Incyte Corporation |
Heterocyclic compounds as immunomodulators
|
|
ES2916874T3
(es)
|
2015-12-17 |
2022-07-06 |
Incyte Corp |
Derivados de N-fenil-piridina-2-carboxamida y su uso como moduladores de la interacción proteína/proteína PD-1/PD-L1
|
|
AU2016379372A1
(en)
|
2015-12-22 |
2018-08-02 |
Incyte Corporation |
Heterocyclic compounds as immunomodulators
|
|
EP3190103A1
(en)
|
2016-01-08 |
2017-07-12 |
Rijksuniversiteit Groningen |
Inhibitors of the pd-1/pd-l1 protein/protein interaction
|
|
AU2017246228B2
(en)
|
2016-04-04 |
2021-04-15 |
Chemocentryx, Inc. |
Soluble C5aR antagonists
|
|
ES2906460T3
(es)
|
2016-05-06 |
2022-04-18 |
Incyte Corp |
Compuestos heterocíclicos como inmunomoduladores
|
|
JP7075928B2
(ja)
|
2016-05-23 |
2022-05-26 |
中国医学科学院薬物研究所 |
フェニレート誘導体、調製及び医薬組成物及び使用
|
|
ES2905980T3
(es)
|
2016-05-26 |
2022-04-12 |
Incyte Corp |
Compuestos heterocíclicos como inmunomoduladores
|
|
BR112018076534A2
(pt)
|
2016-06-20 |
2019-04-02 |
Incyte Corporation |
compostos heterocíclicos como imunomoduladores
|
|
WO2018005374A1
(en)
|
2016-06-27 |
2018-01-04 |
Chemocentryx, Inc. |
Immunomodulator compounds
|
|
US11078192B2
(en)
|
2016-07-05 |
2021-08-03 |
Guangzhou Maxinovel Pharmaceuticals Co., Ltd. |
Aromatic acetylene or aromatic ethylene compound, intermediate, preparation method, pharmaceutical composition and use thereof
|
|
CN109689640B
(zh)
|
2016-07-08 |
2022-01-04 |
百时美施贵宝公司 |
可用作免疫调节剂的化合物
|
|
MA45669A
(fr)
|
2016-07-14 |
2019-05-22 |
Incyte Corp |
Composés hétérocycliques utilisés comme immunomodulateurs
|
|
ES2941716T3
(es)
|
2016-08-29 |
2023-05-25 |
Incyte Corp |
Compuestos heterocíclicos como inmunomoduladores
|
|
US10144706B2
(en)
|
2016-09-01 |
2018-12-04 |
Bristol-Myers Squibb Company |
Compounds useful as immunomodulators
|
|
WO2018045142A1
(en)
|
2016-09-02 |
2018-03-08 |
Polaris Pharmaceuticals, Inc. |
Immune checkpoint inhibitors, compositions and methods thereof
|
|
JP7106572B2
(ja)
|
2016-12-20 |
2022-07-26 |
ブリストル－マイヤーズ スクイブ カンパニー |
免疫調節剤として有用な化合物
|
|
AU2017382870B2
(en)
|
2016-12-22 |
2022-03-24 |
Incyte Corporation |
Benzooxazole derivatives as immunomodulators
|
|
EP3558990B1
(en)
|
2016-12-22 |
2022-08-10 |
Incyte Corporation |
Tetrahydro imidazo[4,5-c]pyridine derivatives as pd-l1 internalization inducers
|
|
ES2899402T3
(es)
|
2016-12-22 |
2022-03-11 |
Incyte Corp |
Derivados de piridina como inmunomoduladores
|
|
WO2018119263A1
(en)
|
2016-12-22 |
2018-06-28 |
Incyte Corporation |
Heterocyclic compounds derivatives as pd-l1 internalization inducers
|
|
ES2874756T3
(es)
|
2016-12-22 |
2021-11-05 |
Incyte Corp |
Derivados de triazolo[1,5-A]piridina como inmunomoduladores
|
|
WO2018119286A1
(en)
|
2016-12-22 |
2018-06-28 |
Incyte Corporation |
Bicyclic heteroaromatic compounds as immunomodulators
|
|
CN106674136B
(zh)
|
2016-12-23 |
2019-07-02 |
中国医科大学 |
嘧啶类抗肿瘤化合物及其制备方法
|
|
EP3564237A4
(en)
|
2016-12-29 |
2020-06-10 |
Shenzhen Chipscreen Biosciences Co., Ltd. |
UREA COMPOUND AND PRODUCTION METHOD AND USE THEREOF
|
|
CN108395443B
(zh)
|
2017-02-04 |
2021-05-04 |
广州丹康医药生物有限公司 |
抑制程序性死亡受体配体1的环状化合物及其用途
|
|
KR20190133714A
(ko)
|
2017-03-27 |
2019-12-03 |
브리스톨-마이어스 스큅 컴퍼니 |
면역조정제로서 유용한 치환된 이소퀴놀린 유도체
|
|
BR102018007822A2
(pt)
|
2017-04-20 |
2018-11-06 |
Gilead Sciences, Inc. |
composto, métodos para inibir pd-1, pd-l1 e/ou interação de pd-1/pd-l1 e para tratamento de câncer, composição farmacêutica, e, kit para tratamento de ou prevenção de câncer ou uma doença ou condição
|
|
TW201841896A
(zh)
|
2017-04-26 |
2018-12-01 |
大陸商南京聖和藥業股份有限公司 |
作為pd—l1抑制劑的雜環類化合物
|
|
CN108863963B
(zh)
|
2017-05-08 |
2022-05-27 |
南京圣和药物研发有限公司 |
作为pd-l1抑制剂的杂环类化合物
|
|
WO2019008156A1
(en)
*
|
2017-07-07 |
2019-01-10 |
Rijksuniversiteit Groningen |
INHIBITORS OF PROTEIN / PROTEIN INTERACTION PD-1 / PD-L1
|
|
AU2018306619B2
(en)
|
2017-07-28 |
2022-06-02 |
Chemocentryx, Inc. |
Immunomodulator compounds
|
|
CN111225665B
(zh)
|
2017-08-08 |
2023-12-08 |
凯莫森特里克斯股份有限公司 |
大环免疫调节剂
|
|
WO2019034172A1
(zh)
|
2017-08-18 |
2019-02-21 |
上海轶诺药业有限公司 |
一种具有pd-l1抑制活性的化合物、其制备方法及用途
|
|
CN118267479A
(zh)
|
2017-09-25 |
2024-07-02 |
凯莫森特里克斯股份有限公司 |
使用趋化因子受体2(ccr2)拮抗剂和pd-1/pd-l1抑制剂的联合治疗
|
|
US20190275015A1
(en)
|
2017-09-25 |
2019-09-12 |
Chemocentryx, Inc. |
Combination therapy using a chemokine receptor 2 (ccr2) antagonist and a pd-1/pd-l1 inhibitor
|
|
US11492375B2
(en)
|
2017-10-03 |
2022-11-08 |
Bristol-Myers Squibb Company |
Cyclic peptide immunomodulators
|
|
CN109665968B
(zh)
|
2017-10-16 |
2022-02-22 |
四川科伦博泰生物医药股份有限公司 |
并环化合物及其制备方法和用途
|
|
CN109678796B
(zh)
|
2017-10-19 |
2023-01-10 |
上海长森药业有限公司 |
Pd-1/pd-l1小分子抑制剂及其制备方法和用途
|
|
CN109721527B
(zh)
|
2017-10-27 |
2024-03-12 |
广州丹康医药生物有限公司 |
一种新型抗pd-l1化合物、其应用及含其的组合物
|
|
KR20200085836A
(ko)
|
2017-11-06 |
2020-07-15 |
주빌런트 프로델 엘엘씨 |
Pd1/pd-l1 활성화 억제제로서의 피리미딘 유도체
|
|
WO2019120297A1
(zh)
|
2017-12-22 |
2019-06-27 |
上海海雁医药科技有限公司 |
免疫调节剂及其制法与医药上的用途
|
|
KR102666727B1
(ko)
|
2017-12-29 |
2024-05-21 |
광저우 맥시노벨 파마수티컬스 씨오., 엘티디. |
방향족 비닐 또는 방향족 에틸계 유도체, 그의 제조방법, 중간체, 약물조성물 및 용도
|
|
JP7214752B2
(ja)
|
2018-01-23 |
2023-01-30 |
ブリストル－マイヤーズ スクイブ カンパニー |
免疫調節剤として有用な２，８－ジアシル－２，８－ジアザスピロ［５．５］ウンデカン化合物
|
|
CA3088927C
(en)
|
2018-02-05 |
2023-03-21 |
Abbisko Therapeutics Co., Ltd. |
Biaryl derivative, preparation method therefor and pharmaceutical use thereof
|
|
TWI707849B
(zh)
|
2018-02-13 |
2020-10-21 |
美商基利科學股份有限公司 |
Pd‐1/pd‐l1抑制劑
|
|
JP7387616B2
(ja)
|
2018-02-22 |
2023-11-28 |
ケモセントリックス，インコーポレイティド |
Ｐｄ－ｌ１アンタゴニストとしてのインダン－アミン
|
|
EP3759093B1
(en)
|
2018-03-01 |
2022-11-30 |
Bristol-Myers Squibb Company |
Compounds useful as immunomodulators
|
|
WO2019174533A1
(zh)
|
2018-03-13 |
2019-09-19 |
广东东阳光药业有限公司 |
Pd-1/pd-l1类小分子抑制剂及其在药物中的应用
|
|
SG11202008950PA
(en)
|
2018-03-13 |
2020-10-29 |
Jubilant Prodel LLC |
Bicyclic compounds as inhibitors of pd1/pd-l1 interaction/activation
|
|
US12083118B2
(en)
*
|
2018-03-29 |
2024-09-10 |
Arbutus Biopharma Corporation |
Substituted 1,1′-biphenyl compounds, analogues thereof, and methods using same
|
|
CR20200520A
(es)
|
2018-03-30 |
2021-03-09 |
Incyte Corp |
Compuestos heterocíclicos como inmunomoduladores
|
|
WO2019192506A1
(en)
|
2018-04-03 |
2019-10-10 |
Betta Pharmaceuticals Co., Ltd |
Immunomodulators, compositions and methods thereof
|
|
KR102591947B1
(ko)
|
2018-04-19 |
2023-10-25 |
길리애드 사이언시즈, 인코포레이티드 |
Pd-1/pd-l1 억제제
|
|
WO2019217821A1
(en)
|
2018-05-11 |
2019-11-14 |
Incyte Corporation |
Tetrahydro-imidazo[4,5-c]pyridine derivatives as pd-l1 immunomodulators
|
|
WO2020011209A1
(zh)
|
2018-07-11 |
2020-01-16 |
上海和誉生物医药科技有限公司 |
免疫抑制剂及其制备方法和在药学上的应用
|
|
WO2020011243A1
(en)
|
2018-07-12 |
2020-01-16 |
Betta Pharmaceuticals Co., Ltd |
Immunomodulators, compositions and methods thereof
|
|
EP3820572B1
(en)
|
2018-07-13 |
2023-08-16 |
Gilead Sciences, Inc. |
Pd-1/pd-l1 inhibitors
|
|
US20210300909A1
(en)
|
2018-07-19 |
2021-09-30 |
Betta Pharmaceuticals Co., Ltd |
Immunomodulators, compositions and methods thereof
|
|
US20210269440A1
(en)
|
2018-07-19 |
2021-09-02 |
Betta Pharmaceuticals Co., Ltd |
Immunomodulators, compositions and methods thereof
|
|
US20210347785A1
(en)
|
2018-08-01 |
2021-11-11 |
Shanghai Ennovabio Pharmaceuticals Co., Ltd. |
Preparation and application of aromatic compound having immunoregulatory function
|
|
US20210236476A1
(en)
|
2018-08-29 |
2021-08-05 |
Chemocentryx, Inc. |
Methods of treating cancer with small molecule pd-l1 inhibitors
|
|
CN109336857A
(zh)
|
2018-11-13 |
2019-02-15 |
南方医科大学 |
一种含取代联苯的黄酮及其应用
|
|
CN109438263A
(zh)
|
2018-11-28 |
2019-03-08 |
南方医科大学 |
一种含取代联苯的萘及其应用
|
|
CN109503546A
(zh)
|
2019-01-10 |
2019-03-22 |
南方医科大学 |
一种间苯二酚二苯甲醚及其应用
|
|
CN109776377B
(zh)
|
2019-02-01 |
2021-08-24 |
沈阳药科大学 |
吲哚啉类化合物及其制备方法和应用
|
|
US20200297708A1
(en)
|
2019-03-19 |
2020-09-24 |
Chemocentryx, Inc. |
Combination Therapy Using a Chemokine Receptor 2 (CCR2) Antagonist and a PD-1 and/or PD-L1 Inhibitor
|
|
CN109776445B
(zh)
|
2019-03-28 |
2022-12-06 |
中国药科大学 |
苯并噁二唑类化合物及其制备方法和医药用途
|
|
AU2020276277B2
(en)
|
2019-05-15 |
2025-03-20 |
Chemocentryx, Inc. |
Triaryl compounds for treatment of PD-L1 diseases
|
|
CN110200959A
(zh)
|
2019-05-30 |
2019-09-06 |
天津科技大学 |
一种黄酮类化合物的应用
|
|
CN110128415B
(zh)
|
2019-05-31 |
2022-03-25 |
沈阳药科大学 |
用作免疫调节剂的吲哚啉类化合物及其制备方法
|
|
SG11202112875UA
(en)
|
2019-06-20 |
2021-12-30 |
Chemocentryx Inc |
Compounds for treatment of pd-l1 diseases
|
|
BR112021025888A2
(pt)
|
2019-07-10 |
2022-04-26 |
Chemocentryx Inc |
Indanos como inibidores de pd-l1
|
|
CN114555080B
(zh)
|
2019-10-16 |
2025-10-10 |
凯莫森特里克斯股份有限公司 |
用于治疗pd-l1疾病的杂芳基联苯胺
|
|
WO2021076890A1
(en)
|
2019-10-16 |
2021-04-22 |
Morphic Therapeutic, Inc. |
INHIBITING HUMAN INTEGRIN α4β7
|
|
AU2020368393B2
(en)
|
2019-10-16 |
2026-01-08 |
Chemocentryx, Inc. |
Heteroaryl-biphenyl amides for the treatment of PD-L1 diseases
|
|
WO2021262627A1
(en)
|
2020-06-23 |
2021-12-30 |
Chemocentryx, Inc. |
Methods of treating cancer using heteroaryl-biphenyl amide derivatives
|